GreenLight Biosciences Holdings, PBC (GRNA) Financial Statements (2024 and earlier)

Company Profile

Business Address 29 HARTWELL AVENUE
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments68,09767157
Cash and cash equivalents68,09767157
Prepaid expense  463 
Deferred costs   181
Other undisclosed current assets3,214  
Total current assets:71,311530338
Noncurrent Assets
Operating lease, right-of-use asset32,766  
Property, plant and equipment41,365  
Asset, held-in-trust  207,012 
Restricted cash and investments1,321  
Other noncurrent assets1,835  
Total noncurrent assets:77,287207,012 
TOTAL ASSETS:148,598207,542338
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:14,38311,7023
Accounts payable839  
Accrued liabilities13,544 3
Other undisclosed accounts payable and accrued liabilities  11,702 
Deferred revenue3,866  
Debt13,439  
Other liabilities724  
Due to related parties  500300
Other undisclosed current liabilities3,14811913
Total current liabilities:35,56012,321315
Noncurrent Liabilities
Long-term debt and lease obligation14,354  
Long-term debt, excluding current maturities14,326  
Finance lease, liability 28  
Liabilities, other than long-term debt50,408  
Other liabilities839  
Operating lease, liability49,569  
Other undisclosed noncurrent liabilities21415,885 
Total noncurrent liabilities:64,97615,885 
Total liabilities:100,53628,206315
Temporary equity, carrying amount  207,000 
Equity
Equity, attributable to parent, including:48,062(27,663)22
Common stock15  
Additional paid in capital468,685 24
Accumulated deficit(420,638)(27,664)(3)
Other undisclosed equity, attributable to parent  11
Total equity:48,062(27,663)22
TOTAL LIABILITIES AND EQUITY:148,598207,542338

Income Statement (P&L) ($ in thousands)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Revenues6,780  
Gross profit:6,780  
Operating expenses(170,699)(13,095) 
Other undisclosed operating income  1,273 
Operating loss:(163,919)(13,095) 
Nonoperating expense(2,044)(1,952) 
Other nonoperating expense(2,044)(1,964) 
Interest and debt expense(4,123)  
Loss from continuing operations before equity method investments, income taxes:(170,086)(15,047) 
Other undisclosed income from continuing operations before income taxes4,123  
Loss from continuing operations before income taxes:(165,963)(15,047) 
Income tax expense(1,092)(2,737) 
Loss from continuing operations:(167,055)(17,784) 
Loss before gain (loss) on sale of properties:(17,784)
Other undisclosed net income 2,724 
Net loss:(167,055)(15,059) 
Other undisclosed net income attributable to parent   
Net loss available to common stockholders, diluted:(167,055)(15,059) 

Comprehensive Income ($ in thousands)

3/31/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net loss:(167,055)(15,059) 
Comprehensive loss, net of tax, attributable to parent:(167,055)(15,059) 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: